microRNA 3960 (MIR3960)

microRNA 3960 (MIR3960) is a small, non-coding RNA molecule (~20-24 nucleotides) that regulates gene expression by binding to target mRNAs, thus repressing their translation or promoting degradation[3]. MIR3960 is part of a cluster with miR-2861 and is strongly induced by the BMP2–Runx2 pathway, crucial for osteoblast differentiation and bone formation[4]. MIR3960 specifically targets and represses Hoxa2, a transcription factor that opposes Runx2's biological activity; this action enhances bone differentiation and homeostasis. Its broader functions may involve epigenetic control, regulation of cell fate, and participation in intricate miRNA-mediated regulatory networks. Although no direct drug interactions are reported, MIR3960's activity and expression hold promise for therapeutic modulation and as a disease biomarker in skeletal disorders[4][3]. If more detailed structural or functional information about druggability or disease linkage emerges in future research, updates may be warranted, but current data position MIR3960 as a specific, functional, and disease-relevant microRNA, especially in skeletal biology.

Other names

MIR3960hsa-mir-3960miR-3960

For molecules targeting MIR3960 (inferred from general microRNA targeting strategies): - Antagomir or microRNA inhibitor: blocks interaction with target mRNA - miRNA mimic: restores normal function if MIR3960 is deficient